Your browser doesn't support javascript.
loading
Drivers of mortality in COVID ARDS depend on patient sub-type.
Cheyne, Helen; Gandomi, Amir; Hosseini Vajargah, Shahrzad; Catterson, Victoria M; Mackoy, Travis; McCullagh, Lauren; Musso, Gabriel; Hajizadeh, Negin.
Afiliação
  • Cheyne H; BioSymetrics, Inc., Huntington, NY, USA.
  • Gandomi A; Institute of Health System Science, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USA; Frank G. Zarb School of Business, Hofstra University, Hempstead, NY, USA.
  • Hosseini Vajargah S; BioSymetrics, Inc., Huntington, NY, USA.
  • Catterson VM; BioSymetrics, Inc., Huntington, NY, USA.
  • Mackoy T; BioSymetrics, Inc., Huntington, NY, USA.
  • McCullagh L; BioSymetrics, Inc., Huntington, NY, USA.
  • Musso G; BioSymetrics, Inc., Huntington, NY, USA. Electronic address: gabe@biosymetrics.com.
  • Hajizadeh N; Institute of Health System Science, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USA; Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Northwell Health, Hempstead, NY, USA. Electronic address: Nhajizadeh@northwell.edu.
Comput Biol Med ; 166: 107483, 2023 Sep 16.
Article em En | MEDLINE | ID: mdl-37748219
ABSTRACT
The most common cause of death in people with COVID-19 is Acute Respiratory Distress Syndrome (ARDS). Prior studies have demonstrated that ARDS is a heterogeneous syndrome and have identified ARDS sub-types (phenoclusters). However, non-COVID-19 ARDS phenoclusters do not clearly apply to COVID-19 ARDS patients. In this retrospective cohort study, we implemented an iterative approach, combining supervised and unsupervised machine learning methodologies, to identify clinically relevant COVID-19 ARDS phenoclusters, as well as characteristics that are predictive of the outcome for each phenocluster. To this end, we applied a supervised model to identify risk factors for hospital mortality for each phenocluster and compared these between phenoclusters and the entire cohort. We trained the models using a comprehensive, preprocessed dataset of 2,864 hospitalized COVID-19 ARDS patients. Our research demonstrates that the risk factors predicting mortality in the overall cohort of COVID-19 ARDS may not necessarily apply to specific phenoclusters. Additionally, some risk factors increase the risk of hospital mortality in some phenoclusters but decrease mortality in others. These phenocluster-specific risk factors would not have been observed with a single predictive model. Heterogeneity in phenoclusters of COVID-19 ARDS as well as the drivers of mortality may partially explain challenges in finding effective treatments for all patients with ARDS.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article